1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
申请人:GlaxoSmithKline
公开号:US07232815B2
公开(公告)日:2007-06-19
The present invention relates to derivatives of 1-oxa-3-aza-dibenzoazulene class, to their pharmacologically acceptable salts and solvates, to processes and intermediates for the preparation thereof as well as to their antiinflammatory actions, especially to the inhibition of tumour necrosis factor-α (TNF-α) production and the inhibition of interleukin-1 (IL-1) production as well as to their analgetic action.
本发明涉及1-氧-3-氮-二苯并并[5,6]蓝色素类的衍生物,其药理学上可接受的盐和溶剂,其制备过程和中间体,以及它们的抗炎作用,特别是对肿瘤坏死因子-α(TNF-α)产生的抑制和对白细胞介素-1(IL-1)产生的抑制,以及其镇痛作用。